Your session is about to expire
← Back to Search
Behavioural Intervention
Neurolens Headache Study
N/A
Waitlist Available
Research Sponsored by Neurolens Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30-40 days
Summary
This trial tests special glasses called neurolens on people aged 18-60 with chronic headaches. The glasses use a special prism to reduce eye strain and improve comfort, which may help alleviate headache symptoms.
Eligible Conditions
- Headache
- Convergence Insufficiency
- Strabismus
- Digital Eye Strain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30-40 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30-40 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Headache Impact Test (HIT-6) questionnaire
Secondary study objectives
Patients with reduced near point of convergence (NPC)
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: NeurolensExperimental Treatment1 Intervention
Our proprietary contoured prism lens design, commercially known as neurolens.
Group II: Control lensPlacebo Group1 Intervention
A simple refractive error correction lens
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Neurolens spectacle lens
2021
N/A
~300
Find a Location
Who is running the clinical trial?
Neurolens Inc.Lead Sponsor
2 Previous Clinical Trials
110 Total Patients Enrolled
Corina Van De Pol, OD PhDStudy DirectorNeurolens Inc.